Research, Policy

Silk Road (SILK): Competition & Coverage

John Leppard, Healthcare Analyst
17 April 2023


Investors of Silk Road Medical have expressed concerns about the competitive risk to the company's TCAR procedure due to CMS reconsidering its coverage restrictions for carotid artery stenting. However, it is unlikely that CMS will create full coverage parity between these procedures in its upcoming proposal.

Want to learn more? Download the Report.


Public Policy Research
Identify opportunity and risks driven by public policy.
Forensic Accounting Research
Understand implications of public company financial reporting.
Fundamental Equity Research
Gain a comprehensive view of global themes, industries, and companies.